NasdaqGM:NPCEMedical Equipment
NeuroPace (NPCE) Q1 Loss Near US$6.7 Million Tests Bullish Profitability Narratives
NeuroPace (NPCE) opened 2026 with Q1 revenue of US$22.1 million and a basic EPS loss of US$0.20, as net income excluding extra items came in at a loss of US$6.7 million. This provides a clear starting point for how the year is shaping up. The company reported quarterly revenue moving from US$22.5 million in Q1 2025 to US$26.6 million in Q4 2025, with basic EPS losses ranging between US$0.26 and US$0.08 over that period. Trailing twelve month revenue reached US$99.5 million against a net loss...